K-State Researchers Designing Better Drug To Treat Cystic Fibrosis

Cystic Fibrosis, also known as mucoviscidosis, is an autosomal recessive hereditary disease, one of the exocrine glands. The disease causes chronic breathing and digestion problems, affecting the lungs, sweat glands and digestive system.

The current treatment for Cystic Fibrosis is daily chest physiotherapy, and aerosol breathing treatments. This involves manual chest percussions, which helps loosening think mucus. Cystic Fibrosis patients are usually hospitalized regularly, often every six months depending on the severity of the case.

There is no known cure to Cystic Fibrosis, but a professor at Kansas State University is spending his time attempting to find a new way to treat Cystic Fibrosis. John Tomich has been working to understand how ions travel across cell membranes, hoping to create a drug which works effectively, and effectively at low doses.

www.medicalnewstoday.com...